• 3611 Citations
  • 26 h-Index
19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Helen K Chew is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Chen, M., Lloyd, K. C., Marcu, L., Chew, H. K., Chaudhari, A. & Yu, A.

National Institutes of Health

7/1/026/30/21

Project: Research project

  • Research Output

    • 3611 Citations
    • 26 h-Index
    • 55 Article

    Preclinical development and first-in-human imaging of the integrin a v b 6 with [ 18 F]a v b 6 -binding peptide in metastatic carcinoma

    Hausner, S. H., Bold, R. J., Cheuy, L. Y., Chew, H. K., Daly, M. E., Davis, R. A., Foster, C. C., Kim, E. & Sutcliffe, J., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1206-1215 10 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations
  • Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study

    Keegan, T. H. M., Kushi, L., Li, Q., Brunson, A., Chawla, X., Chew, H. K., Malogolowkin, M. & Wun, T., Feb 9 2018, (Accepted/In press) In : Journal of Cancer Survivorship. p. 1-10 10 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial

    Hortobagyi, G. N., Van Poznak, C., Harker, W. G., Gradishar, W. J., Chew, H. K., Dakhil, S. R., Haley, B. B., Sauter, N., Mohanlal, R., Zheng, M. & Lipton, A., Jul 1 2017, In : JAMA oncology. 3, 7, p. 906-912 7 p.

    Research output: Contribution to journalArticle

  • 60 Scopus citations

    Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083

    Somlo, G., Frankel, P. H., Arun, B. K., Ma, C. X., Garcia, A. A., Cigler, T., Cream, L. V., Harvey, H. A., Sparano, J. A., Nanda, R., Chew, H. K., Moynihan, T. J., Vahdat, L. T., Goetz, M. P., Beumer, J. H., Hurria, A., Mortimer, J., Piekarz, R., Sand, S., Herzog, J. & 7 others, Van Tongeren, L. R., Ferry-Galow, K. V., Chen, A. P., Ruel, C., Newman, E. M., Gandara, D. R. & Weitzel, J. N., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4066-4076 11 p.

    Research output: Contribution to journalArticle

  • 41 Scopus citations